About Us

Focused on Precision. Driven by Innovation.

Vision

Navigo Proteins® is committed to expanding global access to innovative biotherapeutics by combining proprietary protein-engineering technologies with deep pharmaceutical and biotechnological expertise.

This approach is strengthened by our proprietary protein-engineering technologies and the expertise of globally recognized partners in pharmaceuticals and biotechnology, allowing us to deliver impactful solutions across the entire biotherapeutics value chain.

Our integrated approach focuses on three core areas:

Targeted Treatment Innovation

Next-generation targeted diagnostics and therapeutics for life-threatening and debilitating diseases.

Innovative Bioprocessing

Efficient, scalable biomanufacturing powered by innovative affinity ligands.

Sustainable Commercialization

Driven by a robust bioprocessing business and asset vehicles that advance novel biopharmaceutical products.

Mission

Navigo Proteins® is driven to advance the next generation of biotherapeutics through a unique platform of cutting-edge protein engineering technologies. We continuously strengthen and expand these capabilities within the core-subsidiaries Navigo Pure and Navigo Precision, ensuring that innovation stays at the center of everything we do.

Our mission is powered by proprietary compound libraries, AI-assisted engineering, high-throughput screening, advanced protein purification and analytics, and ISO-certified production capacities. Together, these capabilities allow us to develop transformative, fully patented products that redefine what’s possible in modern biotechnology.

Team & Supervisory Board

Our experienced team of management and biotech scientific leaders includes an interdisciplinary group of specialists in Accounting, Finance, Business Development, Intellectual Property, Bioinformatics, Marketing and Competitive Intelligence, who support our core subsidiaries and asset vehicles in their strategy and business expertise.